IOL Chemicals and Pharmaceuticals Limited

NSEI:IOLCP Stock Report

Market Cap: ₹23.2b

IOL Chemicals and Pharmaceuticals Future Growth

Future criteria checks 2/6

IOL Chemicals and Pharmaceuticals is forecast to grow earnings and revenue by 16.7% and 10.4% per annum respectively. EPS is expected to grow by 16.8% per annum. Return on equity is forecast to be 12.9% in 3 years.

Key information

16.7%

Earnings growth rate

16.8%

EPS growth rate

Pharmaceuticals earnings growth18.7%
Revenue growth rate10.4%
Future return on equity12.9%
Analyst coverage

Low

Last updated19 Apr 2024

Recent future growth updates

Recent updates

Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Aug 30
Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Has A Pretty Healthy Balance Sheet

May 18
IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Has A Pretty Healthy Balance Sheet

IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Will Pay A Dividend Of ₹4.00

Feb 10
IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Will Pay A Dividend Of ₹4.00

Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Jun 07
Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Calculating The Intrinsic Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

May 07
Calculating The Intrinsic Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Do IOL Chemicals and Pharmaceuticals's (NSE:IOLCP) Earnings Warrant Your Attention?

May 04
Do IOL Chemicals and Pharmaceuticals's (NSE:IOLCP) Earnings Warrant Your Attention?

Is IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) An Attractive Dividend Stock?

Mar 13
Is IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) An Attractive Dividend Stock?

Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Feb 23
Is IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?

Should You Rely On IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) Earnings Growth?

Feb 08
Should You Rely On IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) Earnings Growth?

IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Jan 27
IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

How Does IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) CEO Salary Compare to Peers?

Jan 15
How Does IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) CEO Salary Compare to Peers?

Estimating The Intrinsic Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Jan 02
Estimating The Intrinsic Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Shareholders of IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Must Be Delighted With Their 869% Total Return

Dec 21
Shareholders of IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Must Be Delighted With Their 869% Total Return

Is Now The Time To Put IOL Chemicals and Pharmaceuticals (NSE:IOLCP) On Your Watchlist?

Dec 09
Is Now The Time To Put IOL Chemicals and Pharmaceuticals (NSE:IOLCP) On Your Watchlist?

These 4 Measures Indicate That IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Is Using Debt Reasonably Well

Nov 24
These 4 Measures Indicate That IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Is Using Debt Reasonably Well

IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Could Be A Buy For Its Upcoming Dividend

Nov 12
IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Could Be A Buy For Its Upcoming Dividend

Is There More To The Story Than IOL Chemicals and Pharmaceuticals's (NSE:IOLCP) Earnings Growth?

Nov 09
Is There More To The Story Than IOL Chemicals and Pharmaceuticals's (NSE:IOLCP) Earnings Growth?

Will Weakness in IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Stock Prove Temporary Given Strong Fundamentals?

Oct 27
Will Weakness in IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Stock Prove Temporary Given Strong Fundamentals?

Here's What We Think About IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) CEO Pay

Oct 09
Here's What We Think About IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) CEO Pay

Calculating The Fair Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Sep 18
Calculating The Fair Value Of IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Here's Why I Think IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Might Deserve Your Attention Today

Sep 03
Here's Why I Think IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Might Deserve Your Attention Today

Cautious Investors Not Rewarding IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Performance Completely

Aug 16
Cautious Investors Not Rewarding IOL Chemicals and Pharmaceuticals Limited's (NSE:IOLCP) Performance Completely

IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Seems To Use Debt Rather Sparingly

Jul 27
IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Seems To Use Debt Rather Sparingly

Earnings and Revenue Growth Forecasts

NSEI:IOLCP - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202628,4052,491973N/A2
3/31/202526,6502,33185N/A2
3/31/202423,9601,8571,610N/A2
12/31/202322,1611,716N/AN/AN/A
9/30/202322,1921,723622,582N/A
6/30/202322,1531,503N/AN/AN/A
3/31/202322,1711,391-8951,223N/A
12/31/202222,0241,041N/AN/AN/A
9/30/202222,3411,204-538824N/A
6/30/202222,3051,353N/AN/AN/A
3/31/202221,8401,677-602931N/A
12/31/202120,7192,132N/AN/AN/A
9/30/202120,2982,8797032,228N/A
6/30/202120,2543,840N/AN/AN/A
3/31/202119,6704,4462,7163,798N/A
12/31/202019,4814,596N/AN/AN/A
9/30/202019,4634,4282,9023,779N/A
6/30/202018,6184,035N/AN/AN/A
3/31/202018,9453,6133,9054,708N/A
12/31/201918,7533,727N/AN/AN/A
9/30/201918,4233,569N/AN/AN/A
6/30/201918,1633,076N/AN/AN/A
3/31/201916,8532,3672,1262,732N/A
12/31/201815,5061,465N/AN/AN/A
9/30/201813,350731N/AN/AN/A
6/30/201811,298391N/AN/AN/A
3/31/20189,8332777141,197N/A
12/31/20178,891178N/AN/AN/A
9/30/20178,094100N/AN/AN/A
6/30/20178,26565N/AN/AN/A
3/31/20177,10747N/A833N/A
12/31/20166,59539N/AN/AN/A
9/30/20166,197-74N/AN/AN/A
6/30/20166,055-214N/AN/AN/A
3/31/20165,804-400N/A177N/A
12/31/20155,131-692N/AN/AN/A
9/30/20154,377-890N/AN/AN/A
6/30/20154,008-858N/AN/AN/A
3/31/20153,847-667N/A-470N/A
12/31/20144,405-378N/AN/AN/A
9/30/20145,115-71N/AN/AN/A
6/30/20145,45237N/AN/AN/A
3/31/20145,63533N/A784N/A
12/31/20135,68426N/AN/AN/A
9/30/20135,46623N/AN/AN/A
6/30/20134,95917N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IOLCP's forecast earnings growth (16.7% per year) is above the savings rate (6.7%).

Earnings vs Market: IOLCP's earnings (16.7% per year) are forecast to grow slower than the Indian market (17.5% per year).

High Growth Earnings: IOLCP's earnings are forecast to grow, but not significantly.

Revenue vs Market: IOLCP's revenue (10.4% per year) is forecast to grow faster than the Indian market (10% per year).

High Growth Revenue: IOLCP's revenue (10.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IOLCP's Return on Equity is forecast to be low in 3 years time (12.9%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.